Introduction
Wide differences in the choice of coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) for coronary revascularization have been observed among counties in Sweden during recent decades, with a continuous decline in the number of CABGs performed accompanied by an increase in PCIs. In 2015, PCI procedures outnumbered CABGs 9:1, according to the annual report of the national Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART) registry (www.swedeheart.se). Geographic differences in the treatment of ischaemic heart disease have been consistently reported and supposed to be based on accessibility of treatment, referral patterns, ethnic differences, socio-economic status, and patient and physician preferences. The aim of this study was to analyse whether choice of revascularization procedure measured, as the proportion of CABG of all coronary revascularizations in Swedish counties was associated with differences in repeat coronary intervention, non-fatal acute myocardial infarction, and all-cause mortality during follow-up.
Methods
In Sweden, reporting invasive cardiac procedures to national registries is compulsory. The 30 centres performing PCI and the 8 centres performing CABG report the date of surgery and procedure conducted, along with information on patient characteristics, to the national SWEDEHEART health quality registry. This population-based cohort study based on register data comprised all individuals with first-time PCI and isolated CABG performed in Sweden during 2001-11. Patients with previous cardiac intervention or valve replacement or other concomitant surgery were excluded. Information on patient characteristics, date and type of intervention, and date of non-fatal acute non-fatal acute myocardial infarction for the cohort was obtained from SWEDEHEART. The unique 10-digit personal identification number assigned to all Swedish residents was linked to the National Population Registry at Statistics Sweden, enabling identification of the county of residence at the time of the procedure. The date of deaths through 14 April 2015 was obtained from the National Board of Health and Welfare.
Subjects treated for acute ST-elevation myocardial infarction (STEMI) almost exclusively received PCI, and the few STEMI patients managed with emergency CABG could not be adequately identified from registry data. Emergency PCI was not equally available throughout the country. Therefore, STEMI patients were excluded from the final analyses.
The study was approved by the Regional Ethical Review Board in Stockholm (2012/1899-91/1). All data used were anonymous, with cases identified by consecutive numbers, and only aggregate data were reported.
Included variables
Body mass index (BMI) was calculated from weight in kilograms divided by the square of height in metres. Patients were defined as smokers if there was a history of any past or present smoking; hyperlipidaemic if taking lipid-lowering agents; hypertensive if taking anti-hypertension medication; and as having diabetes mellitus if treated by diet or if taking insulin or oral hypoglycaemic agents. Stenosis grade of major coronary artery segments was recorded for all coronary angiographies. Significant coronary artery stenosis was defined as narrowing > _50% of the diameter of one or more main coronary branches, including the left main stem.
Statistical analyses
Descriptive statistics were used to describe group characteristics with number and proportions as categorical variables. The Student's t-test was used to compare differences in means between two patient groups. Age and BMI were presented as arithmetic mean ( x) and standard deviation (SD Figure 1 ). Counties referring a low proportion of patients for CABG consistently did so throughout the sampled period. More males than females underwent revascularization. The proportion of females was higher (29%) in the PCI population than among CABG patients (22%; P < 0.001) ( Table 1) . Both interventions were rare in individuals younger than 40 years, and PCI was more frequently performed than CABG in octogenarians. The mean age at intervention of patients undergoing CABG increased over the study period from 63 to 67 years and remained similar (67 to 68 years) in patients receiving PCI ( Figure 2) . Hyperlipidaemia, hypertension, three-vessel disease, and left main stem stenosis were significantly more common among CABG patients than PCI patients, whereas smoking and diabetes were significantly more common in the PCI group. The patients were followed for a median of 5.1 years. The longest tracking of a patient was 14.3 years. All-cause mortality was significantly higher among CABG patients than in PCI patients, and PCI following initial revascularization was performed more frequently in the PCI group.
Data of 151 936 patients receiving revascularization treatment for non-STEMI or stable coronary artery disease from 2001 to 2011 are presented by quartiles according to the proportion of CABG of all procedures performed. CABG proportions in the quartiles I to IV ranged from 13% to 42% in females and males ( Table 2 ). There were a total of 37 820 events after PCI (36%) and 18 903 after CABG (40%). There were trends of less left main stenosis and lower mortality in PCI patients in counties with higher proportion of CABG. Left main stenosis among CABG patients was most common in counties with the lowest proportion of CABG. Univariate analyses indicated that increased risk for the evaluated combined outcomes was associated with old age, female sex, history of smoking, diabetes mellitus, three-vessel disease, and left main stem stenosis ( Table 3) . Treated hypertension and CABG was associated with a reduced risk.
The multivariable adjusted HR of the combined outcomes was significantly higher for all subjects regardless of the type of intervention in the three quartiles of counties with lower ratios of CABG (QI, QII, and QIII) than in the quartile with the highest ratio of CABG (reference category) ( Table 4) . Following PCI, the adjusted risk was higher in females (HR 1.18, 95% CI 1.07-1.30) and in males (HR 1.26, 95% CI 1.18-1.33) in the quartile with the lowest ratio of CABG (Q1) compared with in the quartile with the highest ratio CABG (Q4). The corresponding figures in the CABG group were HR 1.23 (95% CI 1.07-1.43) and HR 1.34 (95% CI 1.23-1.45).
Excluding repeat interventions did not change the patterns regarding PCI (see Supplementary material online, Table S1 ) nor did including only all-cause mortality when the models were re-examined (see Supplementary material online, or CABG for symptomatic obstructive coronary artery disease during an 11-year period in Sweden.
The reduction in the annual number of CABG procedures reflected an overall increased use of PCI. PCI is increasingly used to treat acute coronary syndrome 1 and is often preferred by patients, as it is a less invasive procedure requiring a shorter period of hospitalization and rehabilitation than does CABG. Physician recommendations and patient preferences regarding the best treatment strategy may differ. We believe that the main reason for our observed regional difference were local clinical strategies and therefore varying compliance to guide1ines. 13 The observed county differences could be partly due to demographic factors, although ageadjusted analyses did not alter our primary findings. Socio-economic conditions vary throughout the country, 14 but health care in Sweden is tax-financed and is not influenced by affordability. There are no restrictions on referring patients to other counties for treatment. Thus, insurance status or procedure availability should not have influenced referral patterns or explain the marked differences among counties. Nevertheless, in counties with direct access to PCI, but not to cardiac surgery, doctors may be more reluctant to refer patients for CABG because of county costs or logistics. As acute PCI is not equally available in emergency situations throughout the country, patients with STEMI were excluded from the study. Long wait times for CABG because of shortage of intensive care surgical beds may influence the type of treatment or divert patients from initially planned CABG to PCI. Some genetic heterogeneity by region exists in Sweden, and differences in coronary pathology by county cannot be excluded but are unlikely. 15 Patients with diabetes mellitus often have multi-vessel coronary disease involving distal segments of coronary branches. 16 CABG is associated with a lower risk of death, myocardial infarction, and repeat revascularization after 5 years compared with stenting with bare metal stents for left main artery or multi-vessel coronary disease among propensity-matched patients. 18, 19 In a propensity-adjusted retrospective analysis of more than 17 000 patients, 5-year mortality was almost 40% lower following CABG than after PCI in patients with three-vessel disease. 20 The 5-year follow-up in the Synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial concluded that CABG should remain the standard of care for patients with complex lesions (SYNTAX score > _23), whereas PCI is an acceptable alternative for treatment of less complex disease or left main coronary artery disease with low or intermediate scores. 21 We are not aware that regionally differing rates of specific revascularization procedures associated with concomitant differences in outcomes have been previously reported. The apparent disadvantage for both CABG and PCI patients managed in counties with lower proportions of CABG procedures in revascularizations compared with those with the highest proportion constitutes an important learning point for coronary revascularization in general. Based on cited literature and our findings, there may be an optimal balance of CABG and PCI. There is a need for national uniform decision-making regarding coronary revascularization. complex multi-vessel coronary artery disease should be discussed by a heart team to reach consensus on best treatment. 13 An important limitation is that no information of stroke during follow-up was available in our database. We were not able to adjust for possible confounders such as medication, left ventricular function, and case-mix characteristics such as lifestyle and socio-economic status, and genetic factors. There may have been missing information about myocardial infarctions and diabetes in CABG patients during the first years of our study period because of incomplete reporting or non-reporting of infarctions in elderly patients with coexisting disease. However, we believe that reporting was similar and accurate for patients undergoing both PCI and CABG. The study population was large and nationwide, and it is unlikely that additional clinical data would have changed our main finding of persisting significant treatment differences among counties in Sweden.
We found significant differences among Swedish counties during an 11-year period in the ratio of CABG to PCI in coronary revascularization. The multivariable-adjusted risk for repeat revascularization, non-fatal myocardial infarction, or death was significantly higher after revascularization, regardless of sex and procedure, in the three quartiles of counties with a lower CABG/PCI ratio compared with the quartile of counties with the highest proportion of CABG. This pattern regarding PCI persisted also after including only all-cause mortality in the analyses. We conclude that there subgroups of patients who have definite prognostic benefits of CABG in addition to symptomatic improvement that is well documented with both PCI and CABG.
